| Literature DB >> 20016695 |
Sang-Wook Kang1, Jung-Suk Choi, Ji-Young Bae, Jing Li, Dong Shoo Kim, Jung-Lye Kim, Seung-Yong Shin, Hyun Ju You, Hyoung-Sook Park, Geun Eog Ji, Young-Hee Kang.
Abstract
The matrix metalloproteinases (MMP) play an important role in tumor invasion, angiogenesis and inflammatory tissue destruction. Increased expression of MMP was observed in benign tissue hyperplasia and in atherosclerotic lesions. Invasive cancer cells utilize MMP to degrade the extracellular matrix and vascular basement membrane during metastasis, where MMP-2 has been implicated in the development and dissemination of malignancies. The present study attempted to examine the antiangiogenic activity of the medicinal herbs of Aspergillus usamii var. shirousamii-transformed Angelicae Gigantis Radix and Zizyphus jujube (tAgR and tZj) with respect to MMP-2 production and endothelial motility in phorbol 12-myristate 13-acetate (PMA)- or VEGF-exposed human umbilical vein endothelial cells (HUVEC). Nontoxic tAgR and tZj substantially suppressed PMA-induced MMP-2 secretion. In addition, 25 microg/mL tAgR and tZj prevented vascular endothelial growth factor-stimulated endothelial cell transmigration and tube formation. The results reveal that tAgR and tZj dampened endothelial MMP-2 production leading to endothelial transmigration and tube formation. tAgR and tZj-mediated inhibition of endothelial MMP may boost a therapeutic efficacy during vascular angiogenesis.Entities:
Keywords: Angelicae Gigantis Radix and Zizyphus jujuba; Angiogenesis; Aspergillus. usamii var. shirousamii; transformation
Year: 2009 PMID: 20016695 PMCID: PMC2788165 DOI: 10.4162/nrp.2009.3.1.3
Source DB: PubMed Journal: Nutr Res Pract ISSN: 1976-1457 Impact factor: 1.926
Fig. 1Cytotoxicity of tAgR (A) and tZj (B) in PMA-exposed HUVEC. After HUVEC were cultured for 24 h in the presence of 50 ng/mL PMA and 1-25 µg/mL tAgR and tZj, MTT assay was performed. The bar graph data represent means ± SEM from 5 independent experiments with multiple estimations. Values are expressed as percent cell survival relative to untreated control cells (cell viability=100%). *P<0.05, compared to untreated control.
Fig. 2Gelatinolytic activity of MMP-2 of PMA-exposed HUVEC treated with 1-25 µg/mL tAgR (A) and tZj (B). After HUVEC culture protocols with 50 ng/mL PMA and 1-25 µg/mL tAgR and tZj for 24 h, equal volumes of culture media were subjected to 10% SDS-PAGE for the measurement of the enzyme activity of MMP-2. Gelatinolytic activity was detected as unstained bands against the background of Coomassie blue-stained gelatin. The bar graphs (means ± SEM, n=4) represent quantitative densitometric results of upper bands. *P<0.05, compared to untreated control. †P<0.05, compared to untreated control and 50 ng/mL PMA.
Fig. 3Inhibition of cell transmigration by tAgR and tZj in VEGF-treated endothelial cells. HUVEC were cultured on gelatin-coated filters of 8 µg/mL pore transwells. Cells transmigrated for 24 h onto the lower surface of the filter were stained with toluidine blue and counted. The bar graphs (means ± SEM, n=4) represent the numbers of cells transmigrated. *P<0.05, compared to untreated control.
Fig. 4Representative images showing tube formation in VEGF-treated endothelial cells plated onto matrigel. After 12 h incubation with 25 µg/mL tAgR and tZj, cells were fixed and images at ×100 magnification were captured. The number of tubes from the images was counted. Multiple five random fields of view were analyzed for the quantitative results. Tube formation results are plotted as means ± SEM (n=4). *P<0.05, compared to VEGF-untreated control.